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implement, it is hoped, a more rational and effective 
management, of patients with severe PHG. 
Main Outcome Measures.-Shunt patency and re- 
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ABSTRACT 
Objective. -To determine the effectiveness of the 
Palmaz balloon expandable stent for the creation of a 
transjugular intrahepatic portosystemic shunt. The 
device is designed to achieve portal decompression in 
patients with variceal hemorrhage secondary to portal 
hypertension. 
Design. -Transjugular intrahepatic portosystemic 
shunting was performed in eight patients during a 
9-month period. Mean follow-up was 5 months. 
Patients. -All patients had cirrhosis with portal 
hypertension and varices. Bleeding occurred in seven 
patients from esophageal varices and in one patient 
from hemorrhoids. 
Results. -Shunts created from a transjugular ap- 
proach between a hepatic and a portal vein (diameters 
of 8 to 12 mm) lowered the average portosystemic 
pressure gradient from 36 to 11 mm Hg. Mean postop- 
erative hospital stay was 7.7 days. Complete variceal 
decompression after transjugular intrahepatic porto- 
systemic shunt placement was identified endoscopi- 
cally in all eight patients. The patient treated for 
hemorrhoids rebled and was treated successfully by 
transfemoral balloon expansion of the shunt diameter 
from 8 to 12 mm. All shunts were patent at 1 to 9 months 
(mean, 5 months) of follow-up. 
Conclusion. -Initial results suggest that trans- 
jugular intrahepatic portosystemic shunt is a safe and 
effective method of portal decompression for the 
treatment of variceal hemorrhage. 
COMMENTS 
The wide variety of treatments available for the 
management of variceal bleeding attests to the com- 
plexity of this problem. Treatments are commonly 
classified according to whether they arrest active 
bleeding, prevent rebleeding or prophylax against po- 
tential bleeding. Not all modalities have comparable 
efficacy for achieving these objectives. This study sum- 
marizes an early experience with a new and innovative 
technique that has potential broad applications for 
managing variceal hemorrhage. Briefly, the technique 
consists of nonsurgically creating a portosystemic shunt. 
Further studies will be needed to establish whether the 
safety, efficacy and cost of a transjugular intrahepatic 
portosystemic shunt (TIPS) compare favorably with 
currently available therapy. 
The first issue will be safety. This study reported no 
acute complications of TIPS although we are not 
provided with data regarding the transfusion require- 
ments associated with the procedure. A prior study of 
nine patients similarly treated had one procedure- 
related fatality (11%) (1). The study used a recent 
technical advance that allows TIPS placement without 
concomitant transhepatic portal venous puncture; this 
appears to  simplify the procedure and may reduce 
morbidity. The explanation for an average postpro- 
cedure hospital stay of 7.7 days in the absence of 
complications is not stated in the manuscript. 
Previous case reports have described TIPS in patients 
with poor hepatic function, in patients who had failed 
sclerotherapy and were deemed inoperable (2) and in a 
patient with intractable ascites caused by malignant 
biliary obstruction (3). Unlike the individuals treated in 
the reviewed study (mostly Child’s class A or B), most 
patients who have variceal hemorrhage are class C 
cirrhotic patients (4). For TIPS to become an accepted 
alternative for reasonable operative candidates, the 
morbidity and mortality rates associated with the 
procedure must be no higher than portosystemic 
shunting in patients with similar severity of liver 
disease. 
The second issue will be efficacy in the prevention of 
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rebleeding. The one patient who rebled in this study 
apparently had suboptimal reduction of portal pressure 
(from 38 to 18 mm Hg) and required stent expansion to 
lower the portosystemic gradient to 8 mm Hg. What 
percentage of patients in larger studies will achieve 
adequate portal decompression to prevent variceal re- 
bleeding? Will these figures compare favorably with the 
effectiveness of surgical shunts (5)? What will be the 
duration of shunt patency after TIPS? The mean 
follow-up in this study was only 5 mo, and two patients 
required balloon angioplasty of the stent to provide 
better decompression during this follow-up. If the 
duration of TIPS patency is shorter than that achieved 
by surgical shunting or if prolonged patency requires 
frequent interval venous portography and angioplasty, 
the procedure may be less applicable than anticipated. 
The final issues to be determined are those of 
long-term complications and the relative cost of TIPS 
compared with other alternatives. The authors report 
that no patient had severe hepatic encephalopathy 
develop after TIPS, although we are not told whether 
milder forms of encephalopathy occurred. One would 
expect that once adequate portal decompression is 
achieved, encephalopathy will occur at a similar rate to 
that after surgical shunting (6). Finally, TIPS will have 
to be compared with medical therapy and sclerotherapy. 
Most clinicians use sclerotherapy as a first-line therapy 
for the prevention of variceal rebleeding and reserve 
surgical shunts for sclerotherapy failures, noncompliant 
patients or patients living in geographically remote 
areas with limited access to medical facilities (7). We 
must also consider what effect TIPS will have on 
subsequent liver transplantation. Presumably avoiding 
dissection of the porta hepatis will reduce the complexity 
of subsequent liver transplantation and thereby may 
reduce postoperative mortality and morbidity rates (8). 
TIPS is an exciting new nonsurgical technique for 
managing variceal hemorrhage caused by portal hyper- 
tension. It is unlikely that this procedure will entirely 
replace other available techniques; rather, it will most 
likely be indicated for the prevention of rebleeding in 
selected groups of patients. Definition of these patient 
groups awaits results from larger studies that are 
needed to establish the safety and efficacy of TIPS 
compared with more well-established techniques for 
managing variceal hemorrhage. 
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PERCUTANEOUS TRANSJUGULAR 
PORTOSYSTEMIC SHUNT: COMMENTARY ON THE 
TECHNICAL ASPECTS OF THIS NEW PROCEDURE 
COMMENTS 
Transjugular intrahepatic portosystemic shunt 
(TIPS) is an exciting new interventional procedure for 
the treatment of portal hypertension that is being 
investigated at several institutions, including the Miami 
Vascular Institute. In its current stage of development, 
TIPS should be performed only in a setting that is as 
ideal as is possible. Angiographic laboratory prerequi- 
sites for the performance of this procedure include 
high-resolution C-arm fluoroscopy, digital subtraction 
angiographic capability, and equipment and personnel 
to provide the patient with adequate analgesia, sedation 
and monitoring during the procedure. High-quality 
ultrasound should be available. Operator skills must 
include experience with standard catheter-guidewire 
manipulations and angioplasty techniques and famil- 
iarity with intrahepatic anatomy and stent deployment 
protocols. 
TIPS presents several technical challenges to the 
experienced interventionist that were not detailed in 
the recent JAMA article by Zemel et al. Transjugular, 
fluoroscopically guided needle puncture of a central 
portal vein branch by way of a hepatic vein is a technique 
still in evolution. Several methods to assist in aiming the 
needle have been used, including transabdominal 
placement of a portal vein catheter, directing the 
puncture toward the expected location of the portal vein 
as demonstrated on previous computed tomography or 
arterial portography and directing the puncture toward 
the portal vein under a combination of fluoroscopic and 
ultrasound guidance. The first method requires a trans- 
abdominal puncture, a possible source of peritoneal 
hemorrhage. The latter two methods avo',d this possible 
complication but may require multiple intrahepatic 
needle passes with a 16-gauge needle - a possible source 
of intrahepatic pseudoaneurysm formation. After an 
